Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based Therapies
Conclusions. The incidence of late recurrent viremia was low. Distinguishing reinfection from virologic relapse has implications for determining true treatment efficiency and selecting optimal retreatment strategies.
Source: Clinical Infectious Diseases - Category: Infectious Diseases Authors: Sarrazin, C., Isakov, V., Svarovskaia, E. S., Hedskog, C., Martin, R., Chodavarapu, K., Brainard, D. M., Miller, M. D., Mo, H., Molina, J.-M., Sulkowski, M. S. Tags: ARTICLES AND COMMENTARIES Source Type: research
More News: Clinical Trials | Genetics | Hepatitis | Hepatitis C | Infectious Diseases | Liver | Urology & Nephrology | Virology